We are live on ! Find out more
CAG

Csenge Advisory Group Portfolio holdings

AUM $2.18B
1-Year Est. Return 16.73%
This Fund
S&P 500
This Quarter Est. Return
+5.65%
1 Year Est. Return
+16.73%
3 Year Est. Return
+51.88%
5 Year Est. Return
+54.25%
10 Year Est. Return
AUM
$1.12B
AUM Growth
-$63.6M
Cap. Flow
-$66.1M
Cap. Flow %
-5.88%
Top 10 Hldgs %
31.27%
Holding
626
New
53
Increased
136
Reduced
339
Closed
80

Sector Composition

Rank Sector Weight
1 Technology 5.3%
2 Financials 4%
3 Healthcare 3.01%
4 Consumer Discretionary 2.96%
5 Communication Services 2.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IP icon
276
International Paper
IP
$22.3B
$666K 0.06%
10,835
-1,342
-11% -$66.2K
CVS icon
277
CVS Health
CVS
$137B
$664K 0.06%
8,081
-676
-8% -$62.5K
FRT icon
278
Federal Realty Investment Trust
FRT
$10.9B
$659K 0.06%
5,579
-17
-0.3% -$2.16K
SCHG icon
279
Schwab US Large-Cap Growth ETF
SCHG
$58.6B
$659K 0.06%
36,016
+12,496
+53% +$250K
BABA icon
280
Alibaba
BABA
$269B
$656K 0.06%
+2,958
New +$431K
SHW icon
281
Sherwin-Williams
SHW
$78.3B
$647K 0.06%
2,348
-158
-6% -$51.1K
MARA icon
282
Marathon Digital Holdings
MARA
$4.62B
$644K 0.06%
20,987
-3,660
-15% -$175K
RF icon
283
Regions Financial
RF
$26.3B
$644K 0.06%
31,538
+190
+0.6% +$4.35K
WMB icon
284
Williams Companies
WMB
$90.5B
$644K 0.06%
24,038
-10,502
-30% -$290K
ADM icon
285
Archer Daniels Midland
ADM
$41.4B
$643K 0.06%
10,597
-119
-1% -$7.69K
SWBI icon
286
Smith & Wesson
SWBI
$655M
$643K 0.06%
18,161
-1,946
-10% -$40.2K
VWO icon
287
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$632K 0.06%
11,699
-143
-1% -$7.21K
JEMD
288
DELISTED
Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share
JEMD
$631K 0.06%
77,700
+5,902
+8% +$45.8K
CL icon
289
Colgate-Palmolive
CL
$72.6B
$627K 0.06%
7,673
+2,397
+45% +$187K
IDXX icon
290
Idexx Laboratories
IDXX
$42.9B
$625K 0.06%
978
-59
-6% -$37K
PYPL icon
291
PayPal
PYPL
$49.5B
$625K 0.06%
2,163
-20
-0.9% -$4.33K
CRL icon
292
Charles River Laboratories
CRL
$10.9B
$620K 0.06%
1,663
-49
-3% -$19K
GS icon
293
Goldman Sachs
GS
$313B
$620K 0.06%
1,652
-204
-11% -$80.8K
LLY icon
294
Eli Lilly
LLY
$1.07T
$618K 0.06%
2,675
-1,655
-38% -$420K
HIG icon
295
Hartford Financial Services
HIG
$38.5B
$617K 0.05%
9,848
-231
-2% -$16.3K
AON icon
296
Aon
AON
$77.3B
$614K 0.05%
2,573
+39
+2% +$11.7K
IYH icon
297
iShares US Healthcare ETF
IYH
$3.11B
$614K 0.05%
11,150
+600
+6% +$34.3K
BA icon
298
Boeing
BA
$165B
$612K 0.05%
2,552
-155
-6% -$32.7K
CMC icon
299
Commercial Metals
CMC
$7.63B
$607K 0.05%
19,484
-909
-4% -$30.1K
MRSH
300
Marsh
MRSH
$86.3B
$607K 0.05%
4,267
-50
-1% -$8.31K

Similar funds

Csenge Advisory Group's Q4 2021 Portfolio in Review

As of Q4 2021, Csenge Advisory Group held 626 positions worth $1.12B, down 5.4% from $1.19B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Csenge Advisory Group withdrew a net $66.1M in Q4 2021, closing 80 positions and reducing 339 holdings. Its most notable exit was iShares US Real Estate ETF, an estimated $1.69M position sold in full.

By sector, the portfolio is most concentrated in Technology at 5.3% of assets, down from 5.4% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Csenge Advisory Group opened a new position in iShares Dow Jones US ETF worth $5M.

  • Csenge Advisory Group's largest Q4 2021 buy was iShares Dow Jones US ETF: 46,062 shares worth $5M.
  • Csenge Advisory Group added most to iShares MSCI All Country Asia ex Japan ETF in Q4 2021, an estimated $4.24M increase.
  • Csenge Advisory Group's biggest Q4 2021 reduction was iShares Core S&P Small-Cap ETF, cutting an estimated $5.3M.
  • Csenge Advisory Group fully exited iShares US Real Estate ETF in Q4 2021, selling an estimated $1.69M.
  • Csenge Advisory Group's ten largest holdings make up 31% of its $1.12B portfolio in Q4 2021.
  • Csenge Advisory Group opened 53 new positions and closed 80 in Q4 2021.
  • Csenge Advisory Group's portfolio value fell 5.4% quarter-over-quarter to $1.12B.

Based on Csenge Advisory Group's 13F filing for Q4 2021, filed 10 Feb 2022.